Quantcast
Drug Trial Restores Hair In Alopecia Areata Sufferers

Drug Trial Restores Hair In Alopecia Areata Sufferers

April Flowers for redOrbit.com - Your Universe Online Baldness, or alopecia, affects millions of people around the world. It can range from male pattern baldness (where the hair thins out gradually) to alopecia universalis (which is a total...

Latest autoimmune diseases Stories

2014-08-20 16:23:24

NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Acclaimed Actress Amy Brenneman may play a silenced police chief's wife in her new role on "The Leftovers," but she generously lends her voice to help raise awareness for Crohn's disease and ulcerative colitis in a newly refreshed public service awareness campaign. To view the multimedia assets associated with this release, please click...

2014-08-20 08:28:32

The Crohn's & Colitis Foundation of America Teams Up with Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Inflammatory Bowel Disease NEW YORK, Aug. 20, 2014 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) announces an agreement with Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) to identify and support the potential development and translation of research in the area of inflammatory bowel disease...

2014-08-20 08:27:57

Be Joint Smart to educate roughly 43,500 local residents with PsA about their disease PORTLAND, Ore., Aug. 20, 2014 /PRNewswire-USNewswire/ -- If you're one of the roughly 43,500 D.C. metro residents struggling with pain from psoriatic arthritis (PsA)--an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons--learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at...

2014-08-19 12:24:46

DANVERS, Mass., Aug. 19, 2014 /PRNewswire-USNewswire/ -- The Scleroderma Foundation presented a Lifetime Achievement Award to Virginia D. Steen, M.D., of Georgetown University Medical Center in Washington, D.C., last month during its National Patient Education Conference held in Anaheim, Calif. Recognized internationally as a leading expert in scleroderma, Dr. Steen has been a longtime ally of the organization and currently is a member of its Medical Advisory Board Steering Committee,...

2014-08-14 12:28:37

Expert from the Largest Scleroderma Specialty Center in the U.S. at Johns Hopkins will Provide Insight to Help Patients, Physicians and Caregivers. SAN FRANCISCO, Aug. 14, 2014 /PRNewswire-USNewswire/ -- Dr. Francisco Boin of the Scleroderma Center at The Johns Hopkins University School of Medicine, one of the largest scleroderma specialty clinics in the world, will host a live, free webinar on Thursday, August 21, 2014 at 1:00 p.m. EDT. The webinar is presented by the Scleroderma...

2014-08-14 04:21:51

CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Aug. 14, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP"), announced today its operating results for the quarter ended June 30, 2014. Dr. Daniel Teper, Chief Executive Officer of Immune Pharmaceuticals, Inc., stated: "Following the completion of a $10.2 million capital raise in March 2014, in the second quarter, we have been able to advance the preparation of Phase II clinical trials...

2014-08-12 11:10:06

Wiley Readmissions more likely in black and Hispanic systemic lupus erythematosus patients A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged. Results published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), show that black and Hispanic SLE patients were more likely to be readmitted than white patients. Readmissions among patients insured by...

2014-08-12 08:31:26

Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4...

2014-08-08 11:12:02

AGA Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients. These data were reported in a new study1 published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association (AGA). Thiopurines are an established treatment for...

2014-08-08 11:10:25

ETH Zurich With a new therapeutic product, researchers have managed to cure arthritis in mice for the first time. The scientists are now planning to test the efficacy of the drug in humans. Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body. The joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it progresses. Rheumatoid arthritis affects 0.5% to 1% of the world’s population. Up to this point, doctors...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related